JAMA Oncology : Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint –Based Therapy in Patients With Advanced NSCLC

Interview with Charu Aggarwal, MD, and Lova Sun, MD, authors of Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Source: JAMA Specialty Journals Author Interviews - April 15, 2021 Category: General Medicine Authors: The JAMA Network Source Type: podcasts